𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum levels of N-acetylaspartate in Huntington's disease: Preliminary results

✍ Scribed by Maddalena Ruggieri; Claudia Serpino; Edmondo Ceci; Vittorio Sciruicchio; Giovanni Franco; Carmela Pica; Maria Trojano; Paolo Livrea; Marina de Tommaso

Book ID
102945956
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
838 KB
Volume
27
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Low brain-derived neurotrophic factor (B
Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients
✍ A. Ciammola; J. Sassone; M. Cannella; S. Calza; B. Poletti; L. Frati; F. Squitie πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 2 views

## Abstract Huntington's disease (HD) is a neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms and by a progressive degeneration of neurons in basal ganglia and in brain cortex. Brain‐derived neurotrophic factor (BDNF) is a pro‐survival factor for striatal neurons

Treatment of the symptoms of Huntington'
Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine
✍ Livia Brusa; Antonio Orlacchio; Vincenzo Moschella; Cesare Iani; Giorgio Bernard πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 438 KB

## Abstract Aripiprazole (AP), a dopamine (DA) D~2~ receptor partial agonist, has recently been used to reduce schizophrenic symptoms, while tetrabenazine (TBZ), a DA depletor, has been used to treat hyperkinesias in Huntington's disease (HD). The aim of this study is to define the role of AP on ch